Open access
124
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort
Wilhelmine H Meeraus1 GlaxoSmithKline plc., Epidemiology – Value, Evidence and Outcomes, Middlesex, UKCorrespondence[email protected]
https://orcid.org/0000-0001-7476-8061
Hana Mullerova1 GlaxoSmithKline plc., Epidemiology – Value, Evidence and Outcomes, Middlesex, UK
https://orcid.org/0000-0002-0949-0101
Céline El Baou2 GlaxoSmithKline plc., Research and Development, Middlesex, UK
https://orcid.org/0000-0002-7212-1835
Marion Fahey1 GlaxoSmithKline plc., Epidemiology – Value, Evidence and Outcomes, Middlesex, UK
, Edith M Hessel2 GlaxoSmithKline plc., Research and Development, Middlesex, UK
https://orcid.org/0000-0002-2339-4482
William A Fahy2 GlaxoSmithKline plc., Research and Development, Middlesex, UK
Pages 225-244
|
Published online: 05 Feb 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.